Adoptive cellular therapy of urological neoplastic disease.
作者信息
Gold J E, Osband M E, Krane R J
机构信息
Department of Medicine, Mount Sinai Hospital, New York, N.Y.
出版信息
Cancer Treat Rev. 1994 Apr;20(2):173-90. doi: 10.1016/0305-7372(94)90026-4.
PMID:8156540
Abstract
摘要
相似文献
1
Adoptive cellular therapy of urological neoplastic disease.
Cancer Treat Rev. 1994 Apr;20(2):173-90. doi: 10.1016/0305-7372(94)90026-4.
2
[Biological response modifiers and urological cancer].
Nihon Hinyokika Gakkai Zasshi. 1992 Jun;83(6):850-6.
3
Cellular therapy: scientific rationale and clinical results in the treatment of metastatic renal-cell carcinoma.细胞疗法：转移性肾细胞癌治疗的科学原理与临床结果
Semin Oncol. 1995 Feb;22(1):74-80.
4
[Cell therapy in renal cell carcinoma].[肾细胞癌的细胞治疗]
Bull Cancer. 2003 Aug-Sep;90(8-9):711-21.
5
Adoptive immunotherapy of urologic tumors.
Cancer Treat Res. 1989;46:213-33. doi: 10.1007/978-1-4613-1595-7_12.
6
Adoptive cellular therapy.过继性细胞疗法
Cancer Chemother Biol Response Modif. 1991;12:213-30.
7
8
[Cell therapy for renal cell carcinoma].[肾细胞癌的细胞治疗]
Gan To Kagaku Ryoho. 2002 Oct;29(10):1745-51.
9
[Immunotherapy and urological malignancy].[免疫疗法与泌尿系统恶性肿瘤]
Nihon Hinyokika Gakkai Zasshi. 1991 Mar;82(3):361-71. doi: 10.5980/jpnjurol1989.82.361.
10
Adoptive immunotherapy with recombinant interleukin 2, LAK and TIL.采用重组白细胞介素2、LAK细胞和TIL细胞进行过继性免疫治疗。
Allergol Immunopathol (Madr). 1991 Sep-Oct;19(5):209-14.
Zotero 插件